Sudan renews medtech prospects:
This article was originally published in Clinica
International healthcare efforts in the Darfur region of Sudan are set to resume, after the government signed a series of security and humanitarian access agreements yesterday. The move is in response to widespread condemnation of the severe social instability in the region. The situation has essentially obviated the calls made in July to meet shortfalls in medical supplies and diagnostic services and hospital infrastructures (see Clinica No 1117, p 13). International efforts were expected to resume last week, after the government signed a series of security and humanitarian access agreements, in response to widespread condemnation of the severe social instability in the region. The UN Security Council met on November 18, in Nairobi, Kenya, to discuss the situation and consider sanctions.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.